Results 211 to 220 of about 13,339,631 (403)

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

Bioinformatic Analysis of WNT Family Proteins. [PDF]

open access: yesBioinform Biol Insights
Midlovets K, Volkova N, Peka M.
europepmc   +1 more source

Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?

open access: yesMolecular Oncology, EarlyView.
 
Chen‐xi Li, Zhong‐cheng Gong
wiley   +1 more source

LC-MS determination of Nicotiana benthamiana host plant proteins in the drug products of recombinant plant-produced pembrolizumab. [PDF]

open access: yesSci Rep
Daduang R   +6 more
europepmc   +1 more source

STUDIES ON THE CX-REACTIVE PROTEIN [PDF]

open access: bronze, 1957
Harrison F. Wood, Sigfrido Montella
openalex   +1 more source

Infrared spectroscopy of proteins.

open access: yesBiochimica et Biophysica Acta, 2007
A. Barth
semanticscholar   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

open access: yesMolecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova   +18 more
wiley   +1 more source

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

open access: hybrid, 1951
OliverH. Lowry   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy